Literature DB >> 30296525

Cholestenoic acid is a prognostic biomarker in acute respiratory distress syndrome.

Jennifer H Madenspacher1, Renee D Stapleton2, Benjamin T Suratt2, Anne E Dixon2, Fred B Lih3, Julie M Lowe1, Kara J Mould4, William J Janssen4, Eric D Morrell5, Mark M Wurfel5, Stavros Garantziotis1, Kenneth B Tomer3, Michael B Fessler6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30296525      PMCID： PMC6322978          DOI： 10.1016/j.jaci.2018.09.017

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

1.  Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy.

Authors:  Katie R Famous; Kevin Delucchi; Lorraine B Ware; Kirsten N Kangelaris; Kathleen D Liu; B Taylor Thompson; Carolyn S Calfee
Journal:  Am J Respir Crit Care Med       Date:  2017-02-01       Impact factor: 21.405

2.  Importance of a novel oxidative mechanism for elimination of intracellular cholesterol in humans.

Authors:  E Lund; O Andersson; J Zhang; A Babiker; G Ahlborg; U Diczfalusy; K Einarsson; J Sjövall; I Björkhem
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-02       Impact factor: 8.311

Review 3.  A New Frontier in Immunometabolism. Cholesterol in Lung Health and Disease.

Authors:  Michael B Fessler
Journal:  Ann Am Thorac Soc       Date:  2017-11

4.  Mitochondrial (dys)function and regulation of macrophage cholesterol efflux.

Authors:  Anne Marie Allen; Janice M W Taylor; Annette Graham
Journal:  Clin Sci (Lond)       Date:  2013-04       Impact factor: 6.124

5.  Elimination of cholesterol as cholestenoic acid in human lung by sterol 27-hydroxylase: evidence that most of this steroid in the circulation is of pulmonary origin.

Authors:  A Babiker; O Andersson; D Lindblom; J van der Linden; B Wiklund; D Lütjohann; U Diczfalusy; I Björkhem
Journal:  J Lipid Res       Date:  1999-08       Impact factor: 5.922

6.  A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury.

Authors:  Renee D Stapleton; Thomas R Martin; Noel S Weiss; Joseph J Crowley; Stephanie J Gundel; Avery B Nathens; Saadia R Akhtar; John T Ruzinski; Ellen Caldwell; J Randall Curtis; Daren K Heyland; Timothy R Watkins; Polly E Parsons; Julie M Martin; Mark M Wurfel; Teal S Hallstrand; Kathryn A Sims; Margaret J Neff
Journal:  Crit Care Med       Date:  2011-07       Impact factor: 7.598

7.  Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport.

Authors:  A Babiker; O Andersson; E Lund; R J Xiu; S Deeb; A Reshef; E Leitersdorf; U Diczfalusy; I Björkhem
Journal:  J Biol Chem       Date:  1997-10-17       Impact factor: 5.157

8.  Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome.

Authors:  Roy G Brower; Paul N Lanken; Neil MacIntyre; Michael A Matthay; Alan Morris; Marek Ancukiewicz; David Schoenfeld; B Taylor Thompson
Journal:  N Engl J Med       Date:  2004-07-22       Impact factor: 91.245

9.  Transport of side-chain oxidized oxysterols in the human circulation.

Authors:  A Babiker; U Diczfalusy
Journal:  Biochim Biophys Acta       Date:  1998-06-15
  9 in total
  1 in total

1.  Macrophage global metabolomics identifies cholestenone as host/pathogen cometabolite present in human Mycobacterium tuberculosis infection.

Authors:  Pallavi Chandra; Héloise Coullon; Mansi Agarwal; Charles W Goss; Jennifer A Philips
Journal:  J Clin Invest       Date:  2022-02-01       Impact factor: 14.808
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.